.svg){kind=small}
Aug-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Stigma Grow has shown a notable performance across different categories and provinces over the past few months. In Alberta, their ranking in the Capsules category has seen a slight decline from the top position in May 2024 to third place by August 2024. Despite this drop, the brand maintained a strong presence in the Concentrates category, improving their rank from 17th in May to 12th in August. This upward trend in Concentrates is indicative of a growing acceptance and preference for Stigma Grow's products in this category within Alberta.
In British Columbia, Stigma Grow's performance in the Capsules category has remained steady, holding the 7th position from June to August 2024. However, their presence in the Concentrates category has significantly improved, moving from 21st in May to 13th in August, showcasing a positive growth trajectory. Meanwhile, in Ontario, the brand has consistently held the 10th position in the Capsules category from June to August, maintaining a stable market presence. This consistency in Ontario, along with the improvements in British Columbia and Alberta, highlights Stigma Grow's strategic positioning and adaptability across different markets.
Competitive Landscape
In the Alberta capsules category, Stigma Grow has experienced notable fluctuations in its market ranking and sales over the past few months. Initially leading the category in May 2024, Stigma Grow dropped to the second position in June and July, and further to the third position in August. This decline in rank coincides with a significant decrease in sales from May to June, followed by a relatively stable but lower sales volume in July and August. In contrast, Glacial Gold has consistently held the top position from June to August, indicating strong and stable market performance. Meanwhile, Ovis and Frank have shown more stable but lower rankings and sales figures, with Frank making a notable jump to the fourth position in July before falling back to sixth in August. These trends suggest that while Stigma Grow remains a key player, it faces stiff competition from Glacial Gold and must strategize to regain its leading position in the Alberta capsules market.
Notable Products
For August 2024, the top-performing product from Stigma Grow is the Indica RSO Capsules 25-Pack (250mg) in the Capsules category, maintaining its position at rank 1 with sales of 5365 units. Following closely in second place is Phoenix Tears RSO (1g) in the Concentrates category, which has consistently held the second rank and saw an increase in sales to 3473 units. The CBD Softgels 15-Pack (750mg CBD) in the Capsules category remains steady at rank 3, despite a decline in sales. Phoenix Tears Honey Oil (1g), also in the Concentrates category, debuted at fourth place with notable sales growth. Lastly, Phoenix Tears Resin (1g) entered the rankings at fifth place, indicating a new interest in this product.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
